StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo operating margin

Operating margin is operating income as a percentage of revenue.

BioLargo's operating margin for the twelve months ending Jun 30, 2026 was -443.9%. For fiscal 2025 it was -191.3%, against -24.4% the year before. The highest annual figure on record is -24.4% in fiscal 2024.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-191.3%−166.9
FY2024Dec 31, 2024-24.4%+13.1
FY2023Dec 31, 2023-37.4%+54.2
FY2022Dec 31, 2022-91.6%+176.2
FY2021Dec 31, 2021-267.8%+44.0
FY2020Dec 31, 2020-311.8%+48.0
FY2019Dec 31, 2019-359.8%+110.3
FY2018Dec 31, 2018-470.1%+672.5
FY2017Dec 31, 2017-1142.6%+612.9
FY2016Dec 31, 2016-1755.5%+1522.0
FY2015Dec 31, 2015-3277.5%−237.1
FY2014Dec 31, 2014-3040.3%−1480.5
FY2013Dec 31, 2013-1559.8%+5638.1
FY2012Dec 31, 2012-7197.9%−5174.0
FY2011Dec 31, 2011-2023.9%+654.4
FY2010Dec 31, 2010-2678.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-298.7%−233.8
Q1 FY2026Mar 31, 2026-287.4%−230.4
Q4 FY2025Dec 31, 2025-650.1%−605.9
Q3 FY2025Sep 30, 2025-651.0%−626.6
Q2 FY2025Jun 30, 2025-64.9%−47.1
Q1 FY2025Mar 31, 2025-57.0%−40.9
Q4 FY2024Dec 31, 2024-44.2%−21.2
Q3 FY2024Sep 30, 2024-24.4%+33.1
Q2 FY2024Jun 30, 2024-17.8%+90.1
Q1 FY2024Mar 31, 2024-16.0%−3.3
Q4 FY2023Dec 31, 2023-23.0%+44.5
Q3 FY2023Sep 30, 2023-57.5%+5.3
Q2 FY2023Jun 30, 2023-107.8%−8.0
Q1 FY2023Mar 31, 2023-12.7%+164.5
Q4 FY2022Dec 31, 2022-67.5%+156.4
Q3 FY2022Sep 30, 2022-62.9%+141.5
Q2 FY2022Jun 30, 2022-99.8%+267.0
Q1 FY2022Mar 31, 2022-177.2%+148.2
Q4 FY2021Dec 31, 2021-224.0%−7.7
Q3 FY2021Sep 30, 2021-204.4%+82.3
Q2 FY2021Jun 30, 2021-366.8%+112.9
Q1 FY2021Mar 31, 2021-325.4%+62.3
Q4 FY2020Dec 31, 2020-216.3%+93.2
Q3 FY2020Sep 30, 2020-286.6%+66.2
Q2 FY2020Jun 30, 2020-479.7%−130.6
Q1 FY2020Mar 31, 2020-387.7%+68.9
Q4 FY2019Dec 31, 2019-309.5%−4.9
Q3 FY2019Sep 30, 2019-352.8%+248.3
Q2 FY2019Jun 30, 2019-349.1%+148.8
Q1 FY2019Mar 31, 2019-456.6%−16.5
Q4 FY2018Dec 31, 2018-304.6%+451.9
Q3 FY2018Sep 30, 2018-601.1%+271.6
Q2 FY2018Jun 30, 2018-497.9%+968.7
Q1 FY2018Mar 31, 2018-440.1%+2669.2
Q4 FY2017Dec 31, 2017-756.5%+1064.5
Q3 FY2017Sep 30, 2017-872.6%−117.6
Q2 FY2017Jun 30, 2017-1466.6%–
Q1 FY2017Mar 31, 2017-3109.3%–
Q4 FY2016Dec 31, 2016-1821.0%–
Q3 FY2016Sep 30, 2016-755.1%–

More BioLargo figures

See a number that looks wrong?